Abstract
Alterations in intestinal microbiota can modulate the developing avian intestinal immune system and, subsequently, may impact on resistance to enteric pathogens. The aim was to demonstrate that early life exposure to Lactococcus lactis, could affect either susceptibility or resistance of broilers to necrotic enteritis (NE). L. lactis NZ9000 (rL. lactis) pre-treatment at 1, 7, 14 and 21 days of age (DOA) led to a significant decrease in NE lesion scores in Clostridium perfringens infected chickens. C. perfringens Infection was associated with spatial and temporal decreases in mononuclear phagocytes and CD4+ αβ T cells. However, rL. Lactis pre-treatment and subsequent C. perfringens infection led to a significant increase in mononuclear phagocytes, CD8α + γδ T, αβ T cells (CD4+ and CD8α+) and B cells (IgM+, IgA+ and IgY+), as well as IL-12p40, IFN-γ and CD40. Differential expression of interleukin (IL)-6, IL-8, IL-10, IL-13, IL-18, IL-22, and transforming growth factor (TGF)-β were observed in L. lactis treated chickens when compared to C. perfringens infected chickens. Microbiota analysis in C. perfringens infected chickens demonstrated an increase in abundance of Bacillota, Bacteroidota, Pseudomonadota and Actinomycetota. These findings suggests that modulation of the chicken intestinal immune system by L. lactis confers partial protection 30 against NE.
Original language | English |
---|---|
Article number | 1257819 |
Journal | Frontiers in Microbiology |
Volume | 14 |
DOIs | |
Publication status | Published - 18 Dec 2023 |
Bibliographical note
Funding Information:The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This research was supported with funds from the Canadian Poultry Research Council, Natural Sciences and Engineering Research Council, Ontario Research Fund-Research Excellence, the Ontario Ministry of Agriculture, Food and Rural Affairs, University of Guelph’s Food from Thought initiative, thanks to funding from the Canada First Research Excellence Fund. SB was supported by funding from the Biotechnology and Biological Sciences Research Council (award no. BBS/E/I/00001825).
Publisher Copyright:
Copyright © 2023 Boodhoo, Shojadoost, Alizadeh, Astill, Behboudi and Sharif.